tiprankstipranks
NAVCO Pharmaceuticals Inc (TSE:NAV)
:NAV
Canadian Market

NAVCO Pharmaceuticals Inc (NAV) Income Statement

Compare
4 Followers

NAVCO Pharmaceuticals Inc Income Statement

Last quarter (Q4 2024), NAVCO Pharmaceuticals Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, NAVCO Pharmaceuticals Inc's net income was $-177.47K. See NAVCO Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ 31.59K$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 43.81K$ 10.66K$ 22.95K$ ―$ ―
EBITDA
$ -2.09M$ -3.33M$ -142.32K$ -74.08K$ -49.56K
Operating Income
$ -2.11M$ -3.34M$ -211.17K$ -79.54K$ -50.70K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.15M$ -3.34M$ -216.39K$ -74.08K$ -49.56K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

NAVCO Pharmaceuticals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis